Skip to content

Role of Cardiac Computed Tomography in Optimising Response to Cardiac Resynchronisation Therapy

Role of Cardiac Computed Tomography and Cardiac Magnetic Resonance in Optimising Response to Cardiac Resynchronisation Therapy

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02434159
Enrollment
100
Registered
2015-05-05
Start date
2012-05-31
Completion date
Unknown
Last updated
2015-05-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure

Brief summary

The purpose of this study is to determine if detailed scanning of the heart before biventricular device insertion will improve outcomes for heart failure patients.

Interventions

OTHERHeart scan

Sponsors

University College, London
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

1. Age \> 18, \<90 2. Patients with moderate or severe heart failure ( NYHA functional class II-IV) due to ischaemic or non-ischaemic cardiomyopathy. 3. QRS duration \>120ms on 12 lead ECG 4. LVEF \< 35% 5. LVEDD \>55 mm 6. Patients on optimum medical treatment for heart failure. The doses of these medications have been stable for 3 months.

Exclusion criteria

1. Patients with a cardiac or cerebral ischemic event within the previous three months prior to recruitment 2. Patients who had had an atrial arrhythmia within one month prior to recruitment 3. Patients with a systolic blood pressure of more than 170 or less than 80 mm Hg 4. Patients with a heart rate of more than 140 beats per minute 5. Patients with severe renal failure (eGFR \< 30) 6. Patients with a history of allergy to iodine based contrast agents 7. Predicted life expectancy \< 1 year 8. Pregnancy

Design outcomes

Primary

MeasureTime frame
6 minute walk test6 months

Countries

United Kingdom

Contacts

Primary ContactVanessa Cobb
nesscobb@hotmail.com

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026